Vilin Bio Med Limited IPO Review & Recommendations
Get Real-Time Updates on stock market trends and news
Get updates on stock market, Stock related news, Algo Trading, learn profitable strategies.
Join WhatsApp ChannelVilin Bio Med Limited IPO
June 16, 2023 - June 21, 2023
Closed
Apply with Angel One
Apply with Zerodha
Pre-Apply with Upstox
Vilin Bio Med Limited IPO Review
Vilin Bio Med Limited was engaged in the domestic business of manufacturing and pharmaceutical products. Their sales approach involves selling their products in large quantities to pharmaceutical manufacturers, marketers, and traders, who then serve as intermediaries for selling to customers. They prioritize high-quality production and strive to provide customers with satisfactory products that meet their expectations. They have a dedicated testing laboratory located within their manufacturing facility, where they conduct thorough product testing.
Their quality control facility is committed to being the industry leader. They closely monitor their products according to rigorous quality standards. vilin biomed limited ipo firmly believe that quality is an ongoing process, and they strive to earn the trust and confidence of their customers by upholding high standards at every level.
Vilin Bio Med Limited Products and Services
vilin bio med ltd products and services are the manufacturing of pharmaceutical formulations such as Dry syrups, Sachets, Beta and Non-Beta Lactam tablets, Capsules & Nutritional Food supplements. They will continue to support well-being and an energetic lifestyle with their portfolio of pharmacy products. Their manufacturing facilities and processes are designed to seamlessly integrate various operations and efficiently scale up production as needed. Their Packaging involves carefully placing pharmaceutical products in a manner that ensures their therapeutic effect is maintained from the moment they are packaged until they are consumed.
Financial Overview
The company operates in a fiercely competitive and fragmented market with numerous players. Vilin Bio Med Limited is engaged in the domestic business of manufacturing. Considering the substantial earnings, the issue seems to be priced with excessive greed, but when considering its past performance, it may be justified. It's perfectly fine to pass on this expensive offering without any negative consequences.
Frequently Asked Question
Vilin Bio Med Limited IPO shares will get listed on June 30, 2023.
Closing date of Vilin Bio Med Limited IPO is June 21, 2023.
Opening date of Vilin Bio Med Limited IPO is June 16, 2023.
Lot size of the Vilin Bio Med Limited IPO is 4000 shares.
Vilin Bio Med Limited IPO share price ₹100 per share.
The face value of Vilin Bio Med Limited IPO is ₹10 per share.
If allotted, you will receive Vilin Bio Med Limited IPO shares in your Demat account on June 29, 2023.
Post-issue shareholding of the Vilin Bio Med Limited IPO promoter is 64.52%.
The meaning of "Vilin Bio Med Limited IPO GMP today" is the Grey Market Premium (GMP) for the initial public offering (IPO) of Vilin Bio Med Limited IPO on the current day.
Pre-issue shareholding of the Vilin Bio Med Limited IPO promoter is 90.45%.
Vilin Bio Med Limited IPO Shares will get listed at NSE SME.
IPO application is an online process by using UPI or ASBA as a payment method. ASBA IPO application is already available in the net banking of your respective bank account and the UPI application is offered by your Stockbroker, you can invest in SVS Limited IPO using any neatest method at your convenience.
If you do not get the allotment of Vilin Bio Med Limited IPO shares, your IPO application amount will be released or credited back to your bank account via which you applied for this IPO.
Minimum and maximum order quantity is 1 lot only.
Comments for Vilin Bio Med Limited IPO Review & Recommendations
0 comments